NASDAQ NMS - GLOBAL MARKET · MLTX
-2.27% · -$0.4064 · Vol 374.1K
Live · updated 15:16:11 ET
MoonLake Immunotherapeutics

MoonLake Immunotherapeutics

Biotechnology
$17.52
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
MLTX
MoonLake Immunotherapeutics
Wed Aug 5 · live session · daily score · 14h old
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

48/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 6/6 factors with data · Wed Aug 5 · live session · daily score · 14h old
Share on X →
Veridion Score History · 90D
Score not reportedVeridion does not publish a score-history trend for MLTX until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
AI Analysis
Sovereign

Why is MLTX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading MLTX catalysts
About MoonLake Immunotherapeutics
PHARMACEUTICAL PREPARATIONS
Listed since
2022
Employees
130
Country
CH

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$17.94
Day high
$18.11
Day low
$17.48
Previous close
$17.93
52W high
$61.99
-71.73% from high
52W low
$6.25
20% of range
Market cap
$1.5B
EPS
$-3.5800
Beta
1.45
Shares out
85.1M
Volume
374.1K
0.29× rel vol
Avg volume
1.3M
VWAP
$17.68
Price history computed in-house
1W
-4.66%
1M
-7.18%
3M
+1.88%
1Y
-67.19%
YTD
+32.96%
SMA 50 $19.07 · below
SMA 200 $16.25 · above
52W position 20%

MLTX overview

Veridion Score
Not reported
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around MLTX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading MLTX Form 4 filings
Public disclosures

Congress activity in MLTX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for MLTX in the cached public ledger.

Federal contracts

MLTX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for MLTX in this window.
Lobbying spend

MLTX lobbying filings, year to date.

Registered lobbying filings matched to MoonLake Immunotherapeutics.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for MLTX in this window.
Loading news for MLTX
Analyst ratings
Sovereign unlock shows live analyst consensus for MLTX.
Options
Sovereign unlock shows live options positioning for MLTX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.